Evergrande Health Industry Group Ltd (0708:HK) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Evergrande Health Industry Group Ltd stock forecast from 0 analysts, the average analyst target price for Evergrande Health Industry Group Ltd is not available over the next 12 months. Evergrande Health Industry Group Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Evergrande Health Industry Group Ltd is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Evergrande Health Industry Group Ltd’s stock price was HKD 0.207. Evergrande Health Industry Group Ltd’s stock price has changed by +0.00% over the past week, -36.31% over the past month and -93.53% over the last year.
No recent analyst target price found for Evergrande Health Industry Group Ltd
No recent average analyst rating found for Evergrande Health Industry Group Ltd
Company Overview Evergrande Health Industry Group Ltd
China Evergrande New Energy Vehicle Group Limited, an investment holding company, engages in the technology research and development, manufacturing, sales, and servicing of new energy vehicles in the People's Republic of China, Europe, and internationally. The company is involved in the development and sale of vehicle living projects; landscaping business; manufacturing and sale of smart mobility products; design, manufacturing, and sale of power lithium-ion batteries; and research and development, manufacturing, and sale of electric vehicles, as well as wholesale of home care and healthcare products. It also provides technical services; and sells vehicles and vehicle components; and other products. The company was formerly known as Evergrande Health Industry Group Limited and changed its name to China Evergrande New Energy Vehicle Group Limited in August 2020. The company was founded in 1999 and is headquartered in Guangzhou, the People's Republic of China. China Evergrande New Energy Vehicle Group Limited operates as a subsidiary of China Evergrande Group. Read Less
China Evergrande New Energy Vehicle Group Limited, an investment holding company, engages in the technology research and development, manufacturing, sales, and servicing of new energy vehicles in the People's Republic of China, Europe, and internationally. The company is involved...Read More
Frequently Asked Questions About Evergrande Health Industry Group Ltd (0708:HK) Stock
Stock Target Advisor's fundamental analysis for Evergrande Health Industry Group Ltd's stock is Bearish.
Unfortunately we do not have enough data on 0708:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 0708:HK's stock to indicate what its average analyst target is.
0708:HK stock's Price/Earning ratio is 121.54.
Our analysis grades 0708:HK stock's Price / Earning ratio at F. This means that 0708:HK stock's Price/Earning ratio is above 91% of the stocks in the Medical Care Facilities sector in the HK exchange.
Based on this 0708:HK may be a overvalued for its sector.
The last closing price of 0708:HK's stock was HKD 0.21.
The most recent market capitalization for 0708:HK is HKD 3.20B.
Unfortunately we do not have enough analyst data on 0708:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Evergrande Health Industry Group Ltd's stock.
As per our most recent records Evergrande Health Industry Group Ltd has 0 Employees.
Evergrande Health Industry Group Ltd's registered address is Evergrande International Center, Guangzhou, China, 510620.
You can get more information about it from Evergrande Health Industry Group Ltd's website at https://www.evergrandehealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0708:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
